Skip to main content
Home

Breadcrumb

  1. Home
  2. News
  3. Search results
Displaying results 1176 - 1200 of 2423 Clear search
Zyme Communications
Mark Gaffney, CEO, Calluna Pharma and Mark Altmeyer, Chairperson of the Board Calluna Pharma
Healthcare and Life Science 09 Oct 2024

Calluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board

Executive appointments will drive growth strategy and progression of clinical pipeline

IPFL
Microfluidic Embedded Electronics ManufacturingMicrofluidic Embedded Electronics Manufacturing
Cleantech and Environment, Healthcare and Life Science, Information Technology and Telecoms, Manufacturing 09 Oct 2024

More on Microfluidic Embedded Electronics Manufacturing

IPFL recently developed a sophisticated component that integrates embedded electronics within a microfluidic system using advanced micro 3D printing technology. Leveraging BMF’s 10µm and 2µm resolution systems, IPFL produced an intricate connector that seamlessly joins two bioreactors, utilizing copper-infused BIO resin for enhanced conductivity and mechanical strength. This project highlights…

electronRx Limited
Healthcare and Life Science, Knowledge Intensive Services 08 Oct 2024

Maximizing the impact of chronic condition data collection

In the realm of healthcare, chronic conditions pose significant challenges for patients, caregivers, and healthcare providers alike. Effective management of chronic conditions requires a nuanced understanding of disease progression, treatment responses, and patient experiences. Data collection plays a pivotal role in this endeavor, offering invaluable insights that can inform clinical decision…

MRC Laboratory of Molecular Biology
Healthcare and Life Science, Science and Engineering 08 Oct 2024

Whole brain connectome of fruit fly is most complex brain ever mapped

The whole brain connectome of the Drosophila fruit fly is the first complete synaptic resolution wiring map of the brain of an adult animal capable of complex behaviours.

Zyme Communications
Barry Davies, CSO,  Mosaic Therapeutics
Healthcare and Life Science 07 Oct 2024

Mosaic Therapeutics appoints Dr Barry Davies as CSO

Former AstraZeneca Senior Director, Global Project Leader adds significant experience and expertise to leadership team Appointment will drive further development of Mosaic’s targeted oncology combination therapies pipeline and platform

C

Zyme Communications
Leica Microsystems’ THUNDER Imager Cell Spinning Disk System
Healthcare and Life Science 07 Oct 2024

CrestOptics and Leica Microsystems announce strategic collaboration to expand capabilities of spinning disk microscopy

Collaboration to incorporate CICERO spinning disk imaging unit within THUNDER Imager Cell system New system launched at Neuroscience 2024 (5th-9th October, Chicago, I
Guardtech Group
Nordics
Cleantech and Environment, Communications, Healthcare and Life Science, Information Technology and Telecoms 07 Oct 2024

Guardtech Group gearing up for Nordics exhibition double at R3 and Tema Renrum

THE GUARDTECH GROUP are all set for an exciting double expo appearance in the Nordics this autumn at the R3 Nordic Annual Symposium & Exhibition in October and Tema Renrum a month later.

Addenbrooke's Charitable Trust (ACT)
Outside multi-terrain area
Charity and Social Care, Healthcare and Life Science 04 Oct 2024

A brand-new centre for prosthetic and orthotic patients celebrates its official opening

The Cambridge Prosthetic and Orthotic Service has recently transferred from clinic nine in Addenbrooke's Hospital to a new base outside the City. Find out here what a difference the amazing new facilities and technology will make to patients

Anglia Ruskin University (ARU)
Healthcare and Life Science 03 Oct 2024

ARU collaborates on new childhood cancer project

Scientists will work with Medannex to help accelerate treatment for bone cancer.

Nxera Pharma UK Ltd
Healthcare and Life Science 03 Oct 2024

Nxera Pharma appoints experienced commercial R&D executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan

Tokyo, Japan and Cambridge, UK – Nxera Pharma Co., Ltd.  – formerly known as Sosei Group or Sosei Heptares – announces the appointment of Dr. Makoto Sugita, M.D., Ph.D., MBA, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (CMO) of Nxera Pharma.

Salus Wellness Clinics
jade
Healthcare and Life Science 03 Oct 2024

Jade Brennan joins Salus Wellness

Salus Wellness are happy to announce that Jade Brennan has joined Salus Wellness this month. Jade is a Permanent Makeup Artist specialising in services to create natural enhancements to the eyebrows, lips and eyes.

Zyme Communications
H.E.L’s iso-BTC e
Healthcare and Life Science 03 Oct 2024

H.E.L Group introduces iso-BTC e to advance semiconductor technologies

New specialized isothermal calorimeter enables direct measurement of heat dissipation and optimization of thermal management and design

electronRx Limited
Challenges and Advances in Asthma Treatment
Healthcare and Life Science 03 Oct 2024

Challenges and advances in asthma treatment

An In-depth Conversation with Dr. Andrew Potter of Whaddon Medical Centre

CMR Surgical
Healthcare and Life Science 02 Oct 2024

Milton Keynes University Hospital purchases second Versius system to bring robotic MAS to more patients

CMR Surgical (CMR) – the global surgical robotics business – has today announced that Milton Keynes University Hospital NHS Foundation Trust (MKUH) have installed their second Versius Surgical Robotic System.

Codon Communications
Yourgene Health & Genetix Logos
Healthcare and Life Science, Science and Engineering 02 Oct 2024

Yourgene Health and Genetix launch first local non-invasive prenatal testing service in Colombia

Genetix will utilise Yourgene Health’s IONA Nx NIPT Workflow to deliver first NIPT service in region Service offers safe, fast and accurate prenatal testing to expectant parents

Manchester, UK, and Bogotá, Colombia, 2 October 2024:

CW (Cambridge Wireless)
Innovation Alley winners pic
Cleantech and Environment, Healthcare and Life Science, Science and Engineering, Other 02 Oct 2024

Celebrating the Cambridge Tech Week Innovation Alley Award winners

We’re delighted to share news and reactions from our Cambridge Tech Week Innovation Alley Award winners for ‘Start-Up of the Year’ and the ‘People’s Choice’ Awards.

Nuclera
nuclera
Healthcare and Life Science, Science and Engineering 02 Oct 2024

Nuclera strengthens team with three key appointments

Dr Gordon McInroy appointed as COO, Dr Tobias Ost as SVP Product Development, and Charu Maini as SVP of People

Zyme Communications
logos
Healthcare and Life Science 02 Oct 2024

ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement

License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services

CRA International (UK) Limited
ESMO 2024 review: Improving patient survival through innovations in oncology
Healthcare and Life Science, Knowledge Intensive Services 01 Oct 2024

ESMO 2024 review: Improving patient survival through innovations in oncology

European Society for Medical Oncology (ESMO) Congress 2024 was held in Barcelona, Spain, bringing together the global oncology community to share the latest data, innovations, and advancements in cancer care.

Crayfish.io
ctw24
Cleantech and Environment, Healthcare and Life Science, Information Technology and Telecoms, Manufacturing 01 Oct 2024

Inspiration, innovation, insights, impact, and collaboration – key takeaways from Cambridge Tech Week 2024

Cambridge Tech Week 2024 (CTW24), held from September 9 to 13, closed on a high, with young talents engaging with the dynamic Cambridge tech ecosystem, fuelling their tech aspirations.

Sphere Bio
Cyto-Mine Chroma
Healthcare and Life Science 01 Oct 2024

Sphere Fluidics announces Cyto-Mine Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development

Next generation of industry-leading Cyto-Mine platform will offer new capabilities to optimize single-cell analysis workflow efficiency Opens up new, multiplexed assays and applications for antibody discovery and cell line development, and allows entry into
CRA International (UK) Limited
Know your customer: Strategic considerations for AI-powered provider segmentation
Healthcare and Life Science, Knowledge Intensive Services 01 Oct 2024

Know your customer: strategic considerations for AI-powered provider segmentation

Published in Life Science Leader, CRA’s Robert Broadnax, Eddie Li and Brian Carpenter co-authored an article “Know Your Customer: Strategic Considerations for AI-Powered Provider Segmentation,” focused on the strategic considerations for drug manufacturers in developing an AI-powered provider seg

CRA International (UK) Limited
Psoriasis patient source of business for major IL-17 agents
Healthcare and Life Science, Knowledge Intensive Services 30 Sep 2024

Psoriasis patient source of business for major IL-17 agents

Source of business for leading IL-17 agents in psoriasis varies significantly by brand. While the majority of Cosentyx patients are previously treated with a TNF inhibitor, a sizable portion of Taltz patients have tried another IL-17 agent before starting Taltz.

CRA International (UK) Limited
Implications of the Inflation Reduction Act for cancer medicine development
Healthcare and Life Science, Knowledge Intensive Services 30 Sep 2024

Implications of the Inflation Reduction Act for cancer medicine development

The Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program (MDPNP) directs the Secretary of Health and Human Services (HHS) to set a maximum price for certain drugs in Medicare.

Owlstone Medical Limited
Owlstone medical logo
Healthcare and Life Science 30 Sep 2024

Owlstone Medical partners with the FDA to advance the identification of volatile organic compounds in breath and expand its Breath Biopsy VOC Atlas.

Collaboration will develop analytical methods to improve the identification of specific chemicals in complex gaseous mixtures Owlstone will use the developed methods and techniques to enhance its work in the field of breath-based biomarkers of disease

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 46
  • Page 47
  • Current page 48
  • Page 49
  • Page 50
  • …
  • Next page ›
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS